GlassScriptPhysician profile
Adam Todd Kramer
NPI 1093971574
$16,521.51
in general payments reported to CMS, 2019-2025
37 companies · $2,288 in 2025
The $2,288 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,217 · 2020: $700 · 2021: $1,239 · 2022: $4,523 · 2023: $3,908 · 2024: $1,647 · 2025: $2,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,902 · Travel and Lodging: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,902.46 |
| Travel and Lodging | $939.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,976.66 | 2020-2025 | Proclaim, Eterna, Octrode |
| Medtronic USA, INC. | $2,025.49 | 2019-2020 | |
| Boston Scientific Corporation | $1,557.73 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Nevro Corp. | $1,335.52 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $798.83 | 2022 | |
| Saluda Medical Americas, INC. | $798.74 | 2023-2025 | Evoke, Evoke Scs |
| Biotronik Nro, INC. | $756.61 | 2023-2025 | Prospera, Biotronik |
| Nalu Medical, INC. | $706.63 | 2021-2024 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $668.47 | 2019-2023 | Intracept |
| Electronic Waveform Lab, INC. | $516.35 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $496.03 | 2019-2025 | Xtampza |
| Medtronic, INC. | $451.26 | 2022-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Vertos Medical, INC. | $383.82 | 2022-2024 | Mild Device Kit |
| Vertiflex, INC. | $208.93 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.44 | 2019-2025 | Relistor |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $96.55 | 2023-2025 | Durolane, Gelsyn-3 |
| Stratus Medical, LLC | $77.74 | 2021-2023 | Nimbus |
| Protega Pharmaceutials INC | $66.74 | 2023-2024 | Roxybond |
| Arbor Pharmaceuticals, INC. | $52.37 | 2020-2022 | |
| Daiichi Sankyo INC. | $49.05 | 2019 | |
| Mml US, INC. | $41.15 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $37.22 | 2019 | |
| Pacira Therapeutics, INC. | $34.27 | 2020 | |
| Averitas Pharma INC. | $33.05 | 2025 | Qutenza |
| Globus Medical, INC. | $31.52 | 2025 | Senza |
| Almatica Pharma LLC | $29.02 | 2023 | Gralise |
| West Therapeutics Development, LLC | $28.99 | 2019 | |
| Team_makena_llc | $19.18 | 2020 | |
| Fidia Pharma USA INC. | $19.08 | 2024 | Hymovis |
| Vertex Pharmaceuticals Incorporated | $17.77 | 2025 | |
| Stryker Corporation | $17.59 | 2025 | Mild Device Kit, Multigen 2 |
| Biohaven Pharmaceuticals, INC. | $16.69 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.60 | 2019 | |
| Pfizer INC. | $13.74 | 2019 | |
| Medline Industries LP | $12.51 | 2019 | |
| Alfasigma USA, INC. | $11.18 | 2021 | |
| Scilex Pharmaceuticals INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.